This inventor holds 1 USPTO granted patent. Top assignee: Prometheus Biosciences, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Michael Bishop and GPR35-Targeted Therapeutics.
Introduction
Michael Bishop is an inventor associated with San Diego, California, and Prometheus Biosciences, Inc. His patent work concerns compounds designed to modulate GPR35, a biological target relevant to potential therapeutic development.
Latest Patents
The supplied information identifies one patent for Michael Bishop: “Therapeutic Agents Targeting GPR35.” It describes compounds of Formula I, or pharmaceutically acceptable salts, as GPR35 modulators that may be useful in preventing or treating GPR35-related diseases, disorders, or conditions, or as remedial agents. The record lists 1 patent.
Career Highlights
Bishop’s listed invention focuses on therapeutic agents that act on GPR35. The supplied information associates his work with Prometheus Biosciences, Inc., a company involved in biotechnology.
Collaborations
The patent information connects Bishop’s invention with Prometheus Biosciences, Inc. No additional collaborators are identified in the supplied details.
Conclusion
Michael Bishop’s listed patent reflects research into GPR35-modulating compounds and their potential use in addressing related diseases and conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile